HA TECH is an Australian based Company, Developing & Delivering innovative Diagnostic and Pharmaceuticals products. HA TECH has a focus on the diagnosis of serious infectious diseases: respiratory Including COVID-19, sexually transmitted infection (STI) and mosquito-borne diseases that affect hundreds of millions of people worldwide and are among the most urgent global health challenges. The Company is making long-term investments to develop pharmaceutical products and medical technologies/ devices to address major health problem in Australia and globally.
Currently HA Tech has production capacity of 40 Million RT PCR test/ month and 10 Million Antigen test/month. We have successfully supplied millions of Covid-19 RT PCR Test kits world wide.
Company Vision:
-As members of the global healthcare community, HA TECH focuses on reducing the burden of disease with our products and development of novel technologies.
-Excellence through Research and Development of Innovative Biotechnology.
Currently HA Tech has production capacity of 40 Million RT PCR test/ month and 10 Million Antigen test/month. We have successfully supplied millions of Covid-19 RT PCR Test kits world wide.
Company Vision:
-As members of the global healthcare community, HA TECH focuses on reducing the burden of disease with our products and development of novel technologies.
-Excellence through Research and Development of Innovative Biotechnology.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
Australia
Year Founded:
2017
Main Therapeutic Focus:
Lead Product in Development:
Diagnostic products for infectious disease such as respiratory, sexually transmitted infections etc.
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
28
Speaker
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
